Goldman Sachs tips The Reject Shop share price to fall to $1.55

About Latest Posts Tom RichardsonTom is a holder of the CFA Society of the UK administered Investment Management Certificate (IMC) …

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Reject Shop Ltd (ASX: TJS) share price is around $2.05 this afternoon but there could be some falls ahead if the analysts at Goldman Sachs are correct in their view of the stock. 

Back on May 23, The Reject Shop shocked investors with a trading update that downgraded its full year profit expectations from a $3.1 million to $4.1 million profit to a $1 million to $2 million loss.

At the same time it also reported that same-store sales for the financial year to date were down 2.7% and down 2.9% for the second half of the financial year. The group predictably blamed the result on the soft local economy, wages growth, and falling house prices. 

Since that trading update the stock has dropped around 10% as investors were not expecting much from this discounted retailer anyway, but Goldman's believes there may be more problems ahead.

In fact after the update it lowered its FY 2019 through to FY 2021 earnings forecasts a staggering 149%, 44% and 42%, which goes to show how analysts' forecasts should not be relied upon as gospel in making investing decisions. 

As a result of its big earnings forecasts downgrades, Goldmans has lowered its 12-month price target on Reject Shop shares to just $1.55.

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »